(Q35605418)

English

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

scientific article published on 17 February 2014

Statements

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial (English)
Andrea Rubbert-Roth
Roman P Korolkiewicz
Arndt J Schottelius

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit